Don Elsey Net Worth & Insider Trades

Don Elsey - Chief Financial Officer, Emergent Biosolutions Inc

As of March 16, 2012

What is Don Elsey's Net Worth?

The current estimated net worth of Emergent Biosolutions Inc's Chief Financial Officer, Don Elsey, is estimated to be about $1.85M . Don Elsey owns about 22,199 units of Emergent Biosolutions Inc common stock. In the last 6 years at Emergent Biosolutions Inc, Don Elsey has sold an estimated value of $2.06M worth.

What is Don Elsey's Past Insider Trading?

Don Elsey's largest purchase order was 24,828 units , worth over $297.92K on November 12, 2008. Don Elsey's largest sale order was 24,828 units , worth over $521.39K on November 12, 2008. In total, Don Elsey has made about 19 transactions over 6 years of their time at Emergent Biosolutions Inc. Don Elsey usually trades in March, with the busiest year in 2008. The most recent transaction was a sale order of 14,385 units , worth over $359.63K on April 19, 2011.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Don Elsey's Salary in 2020?

As Chief Financial Officer of Emergent Biosolutions Inc, Don Elsey has a total base salary of $528,803 . Don Elsey received compensation valued at about $2,159,032 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of stock awards of $700,047 , option awards of $475,413 , other earnings, plans or compensations of $445,204 , and other compensation of $9,565 .

What is Don Elsey's' Mailing Address?

  • Mailing address is 2273 Research Blvd, Suite 400 Rockville MD 20850 MD

Emergent Biosolutions Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Fuad El-Hibri 2020 $1,192,202 $1,200,046 $815,051 - $6,185 $3,213,484
Fuad El-Hibri 2019 $1,131,577 $1,099,949 $773,813 - $4,723 $3,010,062
Fuad El-Hibri 2018 $1,047,031 $957,456 $957,481 - $8,250 $2,970,218
Robert Kramer 2020 $893,860 $2,050,007 $1,392,416 $1,225,020 $8,675 $5,569,978
Robert Kramer 2019 $678,021 $1,439,958 $1,012,999 $557,108 $5,735 $3,693,821
Robert Kramer 2018 $549,047 $649,930 $649,980 $538,807 $8,983 $2,396,747
Richard Lindahl 2020 $549,390 $749,998 $509,425 $462,012 $10,475 $2,281,300
Richard Lindahl 2019 $514,826 $619,984 $436,154 $297,429 $9,104 $1,877,497
Richard Lindahl 2018 $365,393 $557,438 $351,101 $330,007 $8,514 $1,612,453
Adam Havey 2020 $546,507 $700,047 $475,413 $445,204 $8,357 $2,175,528
Adam Havey 2019 $484,120 $619,984 $436,154 $279,579 $25,530 $1,845,367
Adam Havey 2018 $480,728 $499,974 $359,784 $310,212 $8,383 $1,659,081
Atul Saran 2020 $528,803 $700,047 $475,413 $445,204 $9,565 $2,159,032
Atul Saran 2019 $503,774 $619,984 $436,154 $293,567 $9,500 $1,862,979
Atul Saran 2018 $488,730 $527,475 $379,572 $293,567 $8,683 $1,698,027
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm

What are Emergent Biosolutions Inc's Past Insider Trades?

Emergent Biosolutions Inc's most recent insider trade came on November 29, 2022 by Richard S. Lindahl Attorney-In-Fact who sold 1,912 units worth $22.83K . In the last 16 years, insiders at Emergent Biosolutions Inc have sold an estimated value of $238.48M and bought an estimated value of $38.64M worth of shares. Insider trading is most common in May, with the busiest year in 2007. The most active traders at the company are Fuad Elhibri, Director,  Daniel Abdunnabi, CEO,  and Robert Kramer, President and CEO .

Emergent BioSolutions Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...